Propel Health, a leading provider of strategic communications and engagement services to the life sciences industry, announced the appointment of Jeff Keller as President of its Medical Affairs business unit. A seasoned healthcare communications executive with over 30 years of experience, Jeff will lead Propel Health’s efforts to expand...
The acquisition combines eBlu Solutions’ provider-integrated benefit investigation and prior authorization technology with Knipper’s national fulfillment capabilities to accelerate the path from order to therapy.
Knipper Health, a leading therapy initiation partner backed by Frazier Healthcare Partners, announced the acquisition of eBlu Solutions, a provider-integrated technology platform that delivers real-time...
Trinity Life Sciences, a leader in advisory, insights and analytics for the life sciences industry, presented results from a new study demonstrating the potential of an artificial intelligence and machine learning (AIML) model to detect type 1 diabetes (T1D) at least one year before a patient’s clinical diagnosis. Leveraging...
New Data Networks Solutions Library includes native deployment support across Google Cloud Platform, Microsoft Azure, and Amazon Web Services
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, unveiled its new BullFrog Data Networks™...
Asepha is transforming pharmacy operations with interoperable AI agents and Fortune 50 enterprise customers.
Asepha, a fast-growing startup leveraging AI agents for pharmacy automation, announced the close of its $4 million Seed round, led by Glasswing Ventures and Core Innovation Capital. Panache, RedBud, and MGV also participated, with follow-on support...
Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, announced a strategic partnership to develop and clinically validate the first at-home RNA test designed to detect precancerous colon polyps, enabling early prevention...
Resulting technology, called SafeGuide, will enable faster, more cost-effective development of gene edited therapies like CRISPR
Broken String Biosciences, a leader in advancing gene editing safety, and BioLizard, an expert in scientific data analytics and AI, announced the development of SafeGuide, an AI tool for selecting safer, better guide RNAs...
Combined Firm, Known as TandemAI, Will Build on Synergies of Advanced Artificial Intelligence and Computational Platforms for Small Molecule and Peptide-Based Therapeutics
TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a computational design-synthesis platform...
Nabla, one of the most widely adopted clinical AI assistants and Navina, the leading AI-powered clinical intelligence platform for value-based care, announced a strategic partnership to deliver real-time support across the full clinical encounter. The integration combines Navina's clinician co-pilot with Nabla's in-visit ambient documentation, reconciling historical patient records with...
Viome's AI-Powered Platform Delivers Personalized Health Insights and Redefines Wellness Worldwide, Integrating Microsoft Azure
Viome Life Sciences, a leader in AI-powered, RNA-based molecular diagnostics and personalized nutrition, announced a collaboration with Microsoft to accelerate the next generation of preventive and personalized healthcare.
As part of this collaboration, Viome will integrate its dataset...
